Atlas Trials

A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain

Clinical trial NCT00455442 · COMPLETED

Trial details

NCT number
NCT00455442
Sponsor
Corcept Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Weight-Gain Prevention
Start date
2007-03-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.